Association of Gout with Rheumatoid Arthritis and Pulmonary Toxicity of Methotrexate: A Case Report about Algerian Women
Coexistence of rheumatoid arthritis and gout is considered as rare however some patients may gather both diseases. Long-term treatment with Methotrexate may cause pulmonary pathology. We report a case of a 48-year-old Algerian woman with medical history (swelling of knee and joint pain in the shoulders and hands) diagnosed with Rheumatoid Arthritis (RA), after 3 years of self-medication with Methotrexate; she returned with hyperurecimia that confirmed the co-presence of the gout and RA as well as a pneumonia confirmed with clinical sign and chest X-Ray. Methotrexate dose compliance can reduce adverse effects.
Keywords: Rheumatoid arthritis; Gout; Pneumonia; Methotrexate; Toxicity.
2. Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev, 2010; 233:203-17.
3. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006; 440:237-41.
4. Kuo CF, Tsai WP, Liou LB. Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review. Clin Rheumatol, 2008; 27:231–5.
5. Jebakumar AJ, Udayakumar PD, Crowson CS, et al. Occurrenceof gout in rheumatoid arthritis: it does happen! A population-based study. Int J Clin Rheum, 2013; 8:433–7.
6. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum, 2011; 63(10):3136–3141.
7. Gubner R, August S, Ginsberg V. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci, 1951; 221:176-182.
8. Clarysee AM, Cathey WJ, Cartwright GE, et al. Pulmonary disease complicating intermittent therapy with methotrexate. JAMA, 1969; 209:1861e1864.
9. SOSTMAN HD, MATTHAY RA, PUTMAN CE. Cytotoxic drug induced lung disease. Am. J. Med, 1977; 62:608-615.
10. DAY RO, QUINN DI, BROOKS PM, CONAGHAN PG. Hazards of low dose methotrexate. Aust. NZ. J. Med, 1995; 25:670-674.
11. KREMER JM, ALARCON GS, WEINBLATT ME et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature review. Arthritis Rheum, 1997; 40:1829-1837.
12. Yunt, Z. X., & Solomon, J. J. Lung Disease in Rheumatoid Arthritis. Rheumatic Disease Clinics of North America, 2015; 41(2):225–236.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).